Abstract Library

Welcome to the open-access search for all ENETS abstracts presented at the Annual ENETS Conferences.

Everyone can browse the library to find basic information on abstracts. To get full access to each entry, you will be asked to log in to your myENETS account.

 

Please note:

Participants of the 2025 ENETS Conference enjoy full access to the 2025 conference digital resources through myENETS: the abstract booklet, e-posters and videos, slide decks of talks, the poster carousel, and more.

Log in to myENETS

ENETS Abstract Search

#4038 Identification of gastroenteropancreatic neuroendocrine tumor with high liver tumor burden based on clinicopathological features

Introduction: Liver tumor burden (LTB) is a key prognostic factor affecting survival and treatment response of GEP-NET patients. Currently available quantitative assessment of LTB relies on 68Ga-SSA PET/CT scan which is not accessible in some centers.

Conference:

Presenting Author: Chen L

Authors: Jumai N, Chen L, He Q, Liu M, Wen W,

Keywords: liver tumor burden, prediction, neuroendocrine tumor,

#3977 Serum b-HCG as a biomarker in neuroendocrine tumors: A reconsideration of single-analyte approach

Introduction: Despite recent advances, neuroendocrine tumors (NETs) remain a challenging topic due to their diverse characteristics and the lack of suitable biomarkers. The shift to an omics-based approach and the utilization of statistical algorithms present an improvement over the traditional single-analyte strategy, albeit with its own drawbacks.

Conference:

Presenting Author: Komarnicki P

Authors: Komarnicki P, Gut P, Musiałkiewicz J, Maciejewski A, Cieślewicz M,

Keywords: pancreatic neoplasms, neuroendocrine tumor, biomarker, chorionic gonadotropin, hcg-beta,

#3528 Computerized tomography (CT)-based hepatic radiomics phenotypes associate with response to anti-angiogenics in neuroendocrine tumors (NETs): A subanalysis from the phase II TALENT clinical trial

Introduction: The phase II TALENT clinical trial provided evidence of the efficacy of Lenvatinib in patients with panNETs and giNETs. However, the role of radiomic predictive biomarkers of response to antiangiogenic drugs remain unknown.

Conference:

Presenting Author: Garcia Alvarez A

Authors: Garcia Alvarez A, Hernando J, Ligero M, Delgado E, Ibrahim T,

Keywords: Lenvatinib, Radiomics,